FDA approves ‘Pallchek’ for GSK

GlaxoSmithKline has been granted approval by the US Food and Drug Administration (FDA) to use Pall's rapid microbiological test – Pallchek Luminometer – as part of the quality control process for its prescription nasal spray product in a Parma, Italy facility.